| Document Date: 2013-12-16 11:22:54
Open Document File Size: 443,59 KBShare Result on Facebook
City AdenoAssociated Virus / San Diego / Chicago / / Company Ceregene Inc / IL Ceregene Inc. / M.D. / / Facility M.D. Chicago Institute of Neurosurgery / Rush Alzheimer’s Disease Center / M.D. University of California / / IndustryTerm manufacturing process / / MedicalCondition Alzheimer’s Disease / Disease / / Organization FDA / Institute of Neurosurgery and Neuroresearch / Rush Alzheimer’s Disease Center Chicago / WCB / University of California / San Diego / / Person Jeffrey M. Ostrove / David A. Bennett / Raymond T. Bartus / Rush Alzheimer / / Position Principal Investigator / Neurosurgeon / President / Director / VP R&D / / ProvinceOrState California / / Technology Neurosurgery / /
SocialTag |
CERE-110, A Genetically Engineered AdenoAssociated Virus-Based Vector to Deliver Human β- Nerve Growth Factor Protocol: #[removed]Principal Investigator: Neurosurgeon: